Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003913
Filing Date
2025-03-28
Accepted
2025-03-28 08:02:57
Documents
87
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20241231x10k.htm   iXBRL 10-K 2835644
2 EX-4.2 tmb-20241231xex4d2.htm EX-4.2 84441
3 EX-19.1 tmb-20241231xex19d1.htm EX-19.1 78030
4 EX-23.1 tmb-20241231xex23d1.htm EX-23.1 2736
5 EX-31.1 tmb-20241231xex31d1.htm EX-31.1 15417
6 EX-32.1 tmb-20241231xex32d1.htm EX-32.1 7406
  Complete submission text file 0001558370-25-003913.txt   10493157

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20241231.xsd EX-101.SCH 81764
8 EX-101.CAL tmb-20241231_cal.xml EX-101.CAL 61049
9 EX-101.DEF tmb-20241231_def.xml EX-101.DEF 366642
10 EX-101.LAB tmb-20241231_lab.xml EX-101.LAB 563192
11 EX-101.PRE tmb-20241231_pre.xml EX-101.PRE 517677
91 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241231x10k_htm.xml XML 1404321
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38191 | Film No.: 25781541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)